AskNiveshLive·13:08 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to GLAXO

Glaxosmithkline Pharmaceuticals Ltd.: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsMar-25Jun-25Sep-25Dec-25Mar-26
Revenue
9748059801,041995
Other income
4144343236
Expenses
656570662691658
Cost of materials consumed
11512811580113
Purchases of stock-in-trade
291232233217228
Change in inventories
-55-728673
Employee benefit expense
153153138152165
Finance costs
0.600.400.5010.60
Depreciation & amortisation
1516172013
Other expenses
136114151154136
EBITDA
374295372422387
EBIT
360279355401374
Exceptional items
--318-
Profit Before Tax
359279354400373
Tax expense
96749710495
Deferred tax
6-0.4027
Net Profit
263205257296278
Financial Ratios
Operating Profit Margin
36.92%34.71%36.17%38.54%37.55%
EBITDA Margin
38.43%36.63%37.95%40.49%38.87%
Net Profit Margin
27.00%25.47%26.22%28.43%27.94%
Earnings Per Share (₹)
15.5212.1015.0716.5416.40

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.